Elizabeth Chebli

Elizabeth Chebli is a seasoned professional in scientific communications with a focus on oncology, currently serving as Global Senior Director at AstraZeneca since May 2024. With extensive experience in the pharmaceutical industry, Elizabeth has held prominent roles at Bristol Myers Squibb from June 2006 to April 2023, including Executive Director of Worldwide Scientific Content and Market Capabilities, where management of teams across various therapeutic areas was key. In addition to work with Bristol Myers Squibb, Elizabeth has contributed to the Pediatric Advisory Committee at the Robert Wood Johnson Foundation and served as Director of Communications at Coptic Orphans. Prior experience includes a role as Medical Information Manager at Pfizer Pharmaceutical Inc. Elizabeth holds a Pharm.D. from the University of Florida and a BS in Pharmacy from St. John's University.